Search

Your search keyword '"Tanne, D"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Tanne, D" Remove constraint Author: "Tanne, D" Topic myocardial infarction Remove constraint Topic: myocardial infarction
21 results on '"Tanne, D"'

Search Results

1. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

2. Poor neighborhood socioeconomic status and risk of ischemic stroke after myocardial infarction.

3. Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial.

4. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).

5. Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.

6. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.

7. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.

8. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.

9. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome.

10. Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease.

11. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.

12. Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era: the Israeli Thrombolytic National Survey.

13. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups.

14. Stroke risk after anterior wall acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

15. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group.

16. Incidence and prognostic significance of chronic atrial fibrillation among 5,839 consecutive patients with acute myocardial infarction. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

17. Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance and short- and long-term mortality rates. The SPRINT Study Group.

18. Major lipids, apolipoproteins, and risk of vascular disease

19. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

20. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

21. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

Catalog

Books, media, physical & digital resources